Medtech Legal Chief Leaves Amid Company’s Covid-19 Woes

May 11, 2020, 5:42 PM

Stereotaxis Inc., a St. Louis-based medical technology company that’s faced slowing sales due to the Covid-19 pandemic, entered into a separation agreement with chief legal officer and corporate secretary Kevin Barry, according to a May 7 securities filing.

Barry, who has more than two decades of in-house legal and compliance experience in the life sciences and medical technology sector, joined Stereotaxis in November 2018 after serving as vice president of legal affairs at BioFire Diagnostics LLC. His final day at Stereotaxis was April 15, the company said.

Stereotaxis paid $235,811 in total compensation last year to Barry, including $187,000 in ...

To read the full article log in. To learn more about a subscription click here.